Patient demographics and characteristics
Patient . | Age, y . | Sex . | Ethnicity . | Genotype . | Hemoglobin, g/dL . | Platelets, ×109/L . | Normalized spleen volume, multiple of normal . | Normalized liver volume, multiple of normal . | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline . | 6 mo . | 9 mo . | 24 mo . | 48 mo . | Baseline . | 6 mo . | 9 mo . | 24 mo . | 48 mo . | Baseline . | 6 mo . | 9 mo . | 24 mo . | 45 mo . | Baseline . | 6 mo . | 9 mo . | 24 mo . | 45 mo . | |||||
1 | 24 | F | Arab | N370S/N370S | 10.8 | 12.2 | 12.5 | 12.4 | 12.7 | 80 | 123 | 149 | 155 | 130 | 17.5 | 11.0 | 10.0 | 8.0 | 6.5 | 2.3 | 1.8 | 1.9 | 1.5 | 1.2 |
2 | 62 | M | Ashkenazi | N370S/L444P | 12.7 | 14.1 | 14.8 | 14.3 | 14.2 | 69 | 74 | 90 | 127 | 142 | 11.0 | 7.5 | 6.0 | 4.0 | 3.0 | 1.0 | 1.0 | 0.9 | 1.0 | 0.8 |
3 | 35 | M | Ashkenazi | N370S/other | 13.5 | 15.7 | 16.5 | 15.7 | 16.0 | 48 | 95 | 128 | 140 | 151 | 17.5 | 8.0 | 6.5 | * | * | 2.2 | 1.6 | 1.7 | 1.3 | 1.2 |
5 | 35 | F | Ashkenazi | N370S/N370S | 10.6 | 11.7 | 12.0 | 52 | 68 | 72 | 32.5 | 23.0 | 24.5 | 1.7 | 1.8 | 1.6 | ||||||||
6 | 44 | F | Ashkenazi | N370S/IVS2+1 | 10.9 | 56 | 16.0 | 2.1 | ||||||||||||||||
7 | 42 | F | Ashkenazi | N370S/N370S | 10.5 | 12.5 | 12.5 | 13.8 | 13.0 | 37 | 32 | 39 | 42 | 95 | 21.0 | 13.5 | 13.0 | 7.0 | 4.0 | 1.8 | 1.7 | 1.6 | 1.4 | 1.0 |
8 | 23 | F | Romanian | N370S/RecNci | 10.0 | 12.1 | 11.8 | 12.7 | 14.2 | 65 | 137 | 150 | 154 | 203 | 19.0 | 9.0 | 7.0 | 3.5 | 3.5 | 2.2 | 1.6 | 1.6 | 1.2 | 1.2 |
9 | 25 | M | Romanian | N370S/RecNci | 12.6 | 15.8 | 15.9 | 15.8 | 15.1 | 69 | 97 | 120 | 178 | 183 | 28.0 | 12.5 | 10.0 | 4.0 | 2.5 | 2.0 | 1.4 | 1.4 | 1.1 | 0.9 |
10 | 60 | F | Ashkenazi | N370S/N370S | 10.1 | 11.1 | 12.5 | 12.4 | 12.4 | 48 | 60 | 86 | 121 | 139 | 19.0 | 11.0 | 8.5 | 3.5 | 3.0 | 1.4 | 1.2 | 1.0 | 0.8 | 0.8 |
11 | 18 | F | Serbian | N370S/other | 11.0 | 13.8 | 13.6 | 13.6 | 12.6 | 59 | 98 | 110 | 122 | 130 | 15.0 | 9.0 | 8.0 | 5.0 | 3.5 | 1.4 | 1.1 | 1.0 | 1.1 | 0.8 |
12 | 69 | M | Ashkenazi | N370S/N370S | 13.5 | 14.4 | 14.1 | 59 | 65 | 99 | 13.0 | 9.0 | 7.5 | 1.0 | 1.0 | 1.0 | ||||||||
13 | 56 | M | Ashkenazi | N370S/V394L | 12.9 | 15.9 | 16.6 | 15.4 | 16.0 | 46 | 40 | 36 | 111 | 135 | 19.5 | 10.0 | 8.0 | 4.5 | 2.5 | 1.0 | 0.8 | 0.8 | 0.8 | 0.7 |
Patient . | Age, y . | Sex . | Ethnicity . | Genotype . | Hemoglobin, g/dL . | Platelets, ×109/L . | Normalized spleen volume, multiple of normal . | Normalized liver volume, multiple of normal . | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline . | 6 mo . | 9 mo . | 24 mo . | 48 mo . | Baseline . | 6 mo . | 9 mo . | 24 mo . | 48 mo . | Baseline . | 6 mo . | 9 mo . | 24 mo . | 45 mo . | Baseline . | 6 mo . | 9 mo . | 24 mo . | 45 mo . | |||||
1 | 24 | F | Arab | N370S/N370S | 10.8 | 12.2 | 12.5 | 12.4 | 12.7 | 80 | 123 | 149 | 155 | 130 | 17.5 | 11.0 | 10.0 | 8.0 | 6.5 | 2.3 | 1.8 | 1.9 | 1.5 | 1.2 |
2 | 62 | M | Ashkenazi | N370S/L444P | 12.7 | 14.1 | 14.8 | 14.3 | 14.2 | 69 | 74 | 90 | 127 | 142 | 11.0 | 7.5 | 6.0 | 4.0 | 3.0 | 1.0 | 1.0 | 0.9 | 1.0 | 0.8 |
3 | 35 | M | Ashkenazi | N370S/other | 13.5 | 15.7 | 16.5 | 15.7 | 16.0 | 48 | 95 | 128 | 140 | 151 | 17.5 | 8.0 | 6.5 | * | * | 2.2 | 1.6 | 1.7 | 1.3 | 1.2 |
5 | 35 | F | Ashkenazi | N370S/N370S | 10.6 | 11.7 | 12.0 | 52 | 68 | 72 | 32.5 | 23.0 | 24.5 | 1.7 | 1.8 | 1.6 | ||||||||
6 | 44 | F | Ashkenazi | N370S/IVS2+1 | 10.9 | 56 | 16.0 | 2.1 | ||||||||||||||||
7 | 42 | F | Ashkenazi | N370S/N370S | 10.5 | 12.5 | 12.5 | 13.8 | 13.0 | 37 | 32 | 39 | 42 | 95 | 21.0 | 13.5 | 13.0 | 7.0 | 4.0 | 1.8 | 1.7 | 1.6 | 1.4 | 1.0 |
8 | 23 | F | Romanian | N370S/RecNci | 10.0 | 12.1 | 11.8 | 12.7 | 14.2 | 65 | 137 | 150 | 154 | 203 | 19.0 | 9.0 | 7.0 | 3.5 | 3.5 | 2.2 | 1.6 | 1.6 | 1.2 | 1.2 |
9 | 25 | M | Romanian | N370S/RecNci | 12.6 | 15.8 | 15.9 | 15.8 | 15.1 | 69 | 97 | 120 | 178 | 183 | 28.0 | 12.5 | 10.0 | 4.0 | 2.5 | 2.0 | 1.4 | 1.4 | 1.1 | 0.9 |
10 | 60 | F | Ashkenazi | N370S/N370S | 10.1 | 11.1 | 12.5 | 12.4 | 12.4 | 48 | 60 | 86 | 121 | 139 | 19.0 | 11.0 | 8.5 | 3.5 | 3.0 | 1.4 | 1.2 | 1.0 | 0.8 | 0.8 |
11 | 18 | F | Serbian | N370S/other | 11.0 | 13.8 | 13.6 | 13.6 | 12.6 | 59 | 98 | 110 | 122 | 130 | 15.0 | 9.0 | 8.0 | 5.0 | 3.5 | 1.4 | 1.1 | 1.0 | 1.1 | 0.8 |
12 | 69 | M | Ashkenazi | N370S/N370S | 13.5 | 14.4 | 14.1 | 59 | 65 | 99 | 13.0 | 9.0 | 7.5 | 1.0 | 1.0 | 1.0 | ||||||||
13 | 56 | M | Ashkenazi | N370S/V394L | 12.9 | 15.9 | 16.6 | 15.4 | 16.0 | 46 | 40 | 36 | 111 | 135 | 19.5 | 10.0 | 8.0 | 4.5 | 2.5 | 1.0 | 0.8 | 0.8 | 0.8 | 0.7 |
Patient demographics and characteristics at baseline and at select points of evaluation during the phase 1/2 and extension trials including the last values collected for each clinical parameter for the cohort. Normalized liver and spleen volumes are defined as 2.5% and 0.2%, respectively, of total body weight in kilograms.5 Multiples of normal is the observed organ volume divided by the normalized organ volume. By 24 months, all patients demonstrated normalization of hemoglobin concentrations and all but 1 patient demonstrated platelet counts greater than 100 × 109/L.
F indicates female; and M, male.
Spleen volume not interpretable because of technical artifact.